Insider Trading activities of Caliper Life Sciences Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Caliper Life Sciences Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Caliper Life Sciences Inc since year 2005. Table 2 shows the detailed insider transactions of Caliper Life Sciences Inc since 2005. The reporting company's ticker symbol is CALP. The reporting company's CIK number is 1014672.
The total value of stock buying since 2005 is $587,355.
The total value of stock sales since 2005 is $3,035,109.
The total value of stock option exercises since 2005 is $2,125,881.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Caliper Life Sciences Inc (CALP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-11 0 $0 5,000 $52,345 0 $0
2011-10 0 $0 5,000 $52,250 179,407 $862,588
2011-09 0 $0 5,000 $37,600 0 $0
2011-08 0 $0 0 $0 2,472 $16,784
2011-07 0 $0 10,000 $81,020 0 $0
2011-06 0 $0 60,000 $441,077 28,125 $202,500
2011-05 0 $0 15,000 $106,200 0 $0
2011-04 0 $0 10,000 $66,795 0 $0
2011-03 0 $0 28,483 $185,424 0 $0
2011-02 0 $0 0 $0 25,000 $164,250
2011-01 0 $0 17,500 $113,102 0 $0
2010-11 0 $0 9,495 $43,021 0 $0
2010-10 0 $0 20,000 $83,852 0 $0
2010-08 0 $0 12,300 $47,121 0 $0
2010-06 0 $0 39,935 $160,454 74,012 $296,048
2010-05 0 $0 20,400 $81,872 0 $0
2009-08 0 $0 0 $0 10,000 $18,500
2009-06 0 $0 0 $0 32,798 $50,508
2009-04 0 $0 0 $0 8,750 $9,362
2009-03 0 $0 0 $0 19,000 $20,399
2008-08 0 $0 0 $0 10,000 $30,500
2008-07 0 $0 0 $0 20,000 $78,600
2008-06 0 $0 1,500 $5,253 26,202 $85,930
2008-05 0 $0 50,000 $177,011 50,000 $48,346
2008-04 0 $0 25,000 $91,284 33,750 $60,486
2008-03 0 $0 4,700 $19,335 9,000 $34,020
2007-12 0 $0 35,849 $201,278 0 $0
2007-11 0 $0 27,151 $152,898 0 $0
2007-10 0 $0 27,000 $159,309 0 $0
2007-09 0 $0 6,751 $37,435 0 $0
2007-08 0 $0 6,000 $34,380 0 $0
2007-07 0 $0 0 $0 20,000 $97,200
2007-03 0 $0 0 $0 9,000 $49,860
2006-11 0 $0 50,000 $276,293 0 $0
2006-03 87,665 $587,355 50,000 $328,500 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Caliper Life Sciences Inc insiders (CALP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-11-01 Creager Stephen E (Sr. VP and General Counsel) Sale 5,000 10.47 52,345
2011-10-31 Hrusovsky E Kevin (President & CEO) Option Ex 179,407 4.81 862,588
2011-10-03 Creager Stephen E (Sr. VP and General Counsel) Sale 5,000 10.45 52,250
2011-09-01 Creager Stephen E (Sr. VP and General Counsel) Sale 5,000 7.52 37,600
2011-08-09 Hrusovsky E Kevin (President & CEO) Option Ex 2,472 6.79 16,784
2011-07-01 Creager Stephen E (Sr. VP and General Counsel) Sale 5,000 8.11 40,545
2011-07-01 Mcaree Peter F (Sr.VP and CFO) Sale 5,000 8.10 40,475
2011-06-14 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 18,902 7.54 142,577
2011-06-13 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 1,098 7.56 8,300
2011-06-09 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 10,000 7.48 74,800
2011-06-08 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 15,000 7.18 107,700
2011-06-03 Comstock Allan L (Director) Option Ex 4,375 7.20 31,500
2011-06-03 Billet Van (Director) Option Ex 4,375 7.20 31,500
2011-06-03 Milligan David V (Director) Option Ex 4,375 7.20 31,500
2011-06-03 Carter David Warren (Director) Option Ex 4,375 7.20 31,500
2011-06-03 Tunstall Kathryn (Director) Option Ex 4,375 7.20 31,500
2011-06-03 Bishop Robert C (Director) Option Ex 6,250 7.20 45,000
2011-06-01 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 15,000 7.18 107,700
2011-05-25 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 15,000 7.08 106,200
2011-04-01 Creager Stephen E (Sr. VP and General Counsel) Sale 5,000 6.66 33,305
2011-04-01 Mcaree Peter F (Sr.VP and CFO) Sale 5,000 6.70 33,490
2011-03-02 Carter David Warren (Director) Sale 28,483 6.51 185,424
2011-02-23 Hrusovsky E Kevin (President & CEO) Option Ex 25,000 6.57 164,250
2011-01-18 Creager Stephen E (Sr. VP and General Counsel) Sale 10,000 6.44 64,450
2011-01-18 Mcaree Peter F (Sr.VP and CFO) Sale 7,500 6.49 48,652
2010-11-02 Carter David Warren (Director) Sale 9,495 4.53 43,021
2010-10-15 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 4,000 4.24 16,960
2010-10-14 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 4,000 4.20 16,800
2010-10-13 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 4,000 4.20 16,800
2010-10-12 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 5,200 4.16 21,658
2010-10-11 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 2,800 4.16 11,634
2010-08-10 Kruka William C. (Sr VP Corporate Development) Sale 12,300 3.83 47,121
2010-06-11 Carter David Warren (Director) Sale 20,760 4.02 83,538
2010-06-04 Carter David Warren (Director) Sale 14,775 4.01 59,292
2010-06-03 Comstock Allan L (Director) Option Ex 11,513 4.00 46,052
2010-06-03 Billet Van (Director) Option Ex 11,513 4.00 46,052
2010-06-03 Milligan David V (Director) Option Ex 11,513 4.00 46,052
2010-06-03 Carter David Warren (Director) Sale 2,000 4.00 8,000
2010-06-03 Carter David Warren (Director) Option Ex 11,513 4.00 46,052
2010-06-03 Tunstall Kathryn (Director) Option Ex 11,513 4.00 46,052
2010-06-03 Bishop Robert C (Director) Option Ex 16,447 4.00 65,788
2010-06-02 Carter David Warren (Director) Sale 2,400 4.01 9,624
2010-05-28 Carter David Warren (Director) Sale 3,000 4.00 12,011
2010-05-24 Carter David Warren (Director) Sale 17,400 4.02 69,861
2009-08-17 Hrusovsky E Kevin (President & CEO) Option Ex 10,000 1.85 18,500
2009-06-04 Comstock Allan L (Director) Option Ex 5,102 1.54 7,857
2009-06-04 Billet Van (Director) Option Ex 5,102 1.54 7,857
2009-06-04 Milligan David V (Director) Option Ex 5,102 1.54 7,857
2009-06-04 Carter David Warren (Director) Option Ex 5,102 1.54 7,857
2009-06-04 Tunstall Kathryn (Director) Option Ex 5,102 1.54 7,857
2009-06-04 Bishop Robert C (Director) Option Ex 7,288 1.54 11,223
2009-04-06 Hrusovsky E Kevin (President & CEO) Option Ex 8,750 1.07 9,362
2009-03-30 Hrusovsky E Kevin (President & CEO) Option Ex 9,000 1.00 9,000
2009-03-06 Hrusovsky E Kevin (President & CEO) Option Ex 10,000 1.14 11,399
2008-08-18 Hrusovsky E Kevin (President & CEO) Option Ex 10,000 3.05 30,500
2008-07-30 Hrusovsky E Kevin (President & CEO) Option Ex 20,000 3.93 78,600
2008-06-06 Comstock Allan L (Director) Option Ex 4,117 3.42 14,080
2008-06-06 Billet Van (Director) Option Ex 4,117 3.42 14,080
2008-06-06 Milligan David V (Director) Option Ex 4,117 3.42 14,080
2008-06-06 Carter David Warren (Director) Option Ex 4,117 3.42 14,080
2008-06-06 Tunstall Kathryn (Director) Option Ex 4,117 3.42 14,080
2008-06-06 Bishop Robert C (Director) Option Ex 4,117 3.42 14,080
2008-06-03 Kisner Daniel L (Other) Sale 1,200 3.50 4,200
2008-06-03 Kisner Daniel L (Other) Option Ex 1,200 .97 1,160
2008-06-02 Kisner Daniel L (Director) Sale 300 3.51 1,053
2008-06-02 Kisner Daniel L (Director) Option Ex 300 .97 290
2008-05-30 Kisner Daniel L (Director) Sale 8,412 3.50 29,442
2008-05-30 Kisner Daniel L (Director) Option Ex 8,412 .97 8,134
2008-05-19 Kisner Daniel L (Director) Sale 13,510 3.50 47,352
2008-05-19 Kisner Daniel L (Director) Option Ex 13,510 .97 13,064
2008-05-16 Kisner Daniel L (Director) Sale 3,078 3.50 10,788
2008-05-16 Kisner Daniel L (Director) Option Ex 3,078 .97 2,976
2008-05-13 Kisner Daniel L (Director) Sale 617 3.50 2,159
2008-05-13 Kisner Daniel L (Director) Option Ex 617 .97 596
2008-05-06 Kisner Daniel L (Director) Sale 2,400 3.54 8,486
2008-05-06 Kisner Daniel L (Director) Option Ex 2,400 .97 2,320
2008-05-05 Kisner Daniel L (Director) Sale 6,583 3.53 23,211
2008-05-05 Kisner Daniel L (Director) Option Ex 6,583 .97 6,365
2008-05-02 Kisner Daniel L (Director) Sale 9,600 3.60 34,560
2008-05-02 Kisner Daniel L (Director) Option Ex 9,600 .97 9,283
2008-05-01 Kisner Daniel L (Director) Sale 5,800 3.62 21,013
2008-05-01 Kisner Daniel L (Director) Option Ex 5,800 .97 5,608
2008-04-16 Kisner Daniel L (Director) Sale 5,300 3.61 19,138
2008-04-16 Kisner Daniel L (Director) Option Ex 5,300 .97 5,125
2008-04-15 Kisner Daniel L (Director) Sale 6,000 3.66 21,936
2008-04-15 Kisner Daniel L (Director) Option Ex 6,000 .97 5,802
2008-04-14 Kisner Daniel L (Director) Sale 13,700 3.66 50,210
2008-04-14 Kisner Daniel L (Director) Option Ex 13,700 .97 13,247
2008-04-04 Hrusovsky E Kevin (President & CEO) Option Ex 8,750 4.15 36,312
2008-03-29 Hrusovsky E Kevin (President & CEO) Option Ex 9,000 3.78 34,020
2008-03-14 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 4,700 4.11 19,335
2007-12-20 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 1,720 5.50 9,460
2007-12-19 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 780 5.53 4,310
2007-12-17 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 6,500 5.63 36,621
2007-12-10 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 9,000 5.81 52,272
2007-12-03 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 17,849 5.52 98,615
2007-11-30 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 18,151 5.59 101,409
2007-11-05 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 9,000 5.72 51,489
2007-10-29 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 9,000 5.88 52,938
2007-10-22 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 9,000 5.80 52,236
2007-10-15 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 9,000 6.02 54,135
2007-09-14 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 2,000 5.42 10,840
2007-09-10 Mcaree Peter F (Vice President of Finance) Sale 2,801 5.55 15,551
2007-09-07 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 1,680 5.65 9,492
2007-09-06 Mcaree Peter F (Vice President of Finance) Sale 270 5.75 1,552
2007-08-23 Creager Stephen E (VP and General Counsel) Sale 3,000 5.77 17,310
2007-08-22 Creager Stephen E (VP and General Counsel) Sale 3,000 5.69 17,070
2007-07-30 Hrusovsky E Kevin (President & CEO) Option Ex 20,000 4.86 97,200
2007-03-29 Hrusovsky E Kevin (President & CEO) Option Ex 9,000 5.54 49,860
2006-11-30 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 8,882 5.53 49,117
2006-11-28 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 41,118 5.52 227,176
2006-03-14 Manyak David M (Exec VP, Drug Discovery Svcs) Sale 50,000 6.57 328,500
2006-03-08 Platinum Asset Management Ltd (10% Owner) Buy 87,665 6.70 587,355

Insider trading activities including stock purchases, stock sales, and option exercises of CALP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Caliper Life Sciences Inc (symbol CALP, CIK number 1014672) see the Securities and Exchange Commission (SEC) website.